Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current

Circulation Research

Volumn 103, Issue 8, 2008, Pages 845-854

  Qi, Xiao Yan ^a   Yeh, Yung Hsin ^a,c   Xiao, Ling ^a,b   Burstein, Brett ^a   Maguy, Ange ^a   Chartier, Denis ^a   Villeneuve, Louis R ^a   Brundel, Bianca J J M ^b,d   Dobrev, Dobromir ^e   Nattel, Stanley ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Antiarrhythmic therapy; Arrhythmia mechanisms; Atrial fibrillation; Electrophysiological remodeling

Indexed keywords

CALCINEURIN; CALCIUM CHANNEL L TYPE; CALCIUM ION; CALMODULIN; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; MESSENGER RNA; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; NIMODIPINE; TACROLIMUS; TRANSCRIPTION FACTOR NFAT; 1,2 BIS(2 AMINOPHENOXY)ETHANE N,N,N',N' TETRAACETIC ACID ACETOXYMETHYL ESTER; 1,2-BIS(2-AMINOPHENOXY)ETHANE N,N,N',N'-TETRAACETIC ACID ACETOXYMETHYL ESTER; CALCIUM CHANNEL BLOCKING AGENT; CHELATING AGENT; DRUG DERIVATIVE; EGTAZIC ACID; L TYPE CALCIUM CHANNEL ALPHA(1C); L-TYPE CALCIUM CHANNEL ALPHA(1C); POTASSIUM; SULFONAMIDE;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; DOWN REGULATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; ION CURRENT; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUPRAVENTRICULAR TACHYCARDIA; TRANSCRIPTION REGULATION; WESTERN BLOTTING; ANIMAL; CALCIUM SIGNALING; CELL CULTURE; DOG; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; HEART ATRIUM; HEART PACING; METABOLISM; TIME;

ACTION POTENTIALS; ANIMALS; CALCINEURIN; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CALMODULIN; CARDIAC PACING, ARTIFICIAL; CELLS, CULTURED; CHELATING AGENTS; DOGS; EGTAZIC ACID; HEART ATRIA; MYOCYTES, CARDIAC; NFATC TRANSCRIPTION FACTORS; NIMODIPINE; POTASSIUM; RNA, MESSENGER; SULFONAMIDES; TACHYCARDIA, SUPRAVENTRICULAR; TACROLIMUS; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 54449090309     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.108.175463     Document Type: Article

References (41)

1. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946-952.
2. Nattel S. New ideas about atrial fibrillation 50 years on. Nature. 2002; 415:219-226.
3. Wijffels MC, Kirchhof CJ, Dorland R, Power J, Allessie MA. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation. 1997;96:3710-3720.
4. Yue L, Feng J, Gaspo R, Li GR, Wang Z, Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res. 1997;81:512-525.
5. van der Velden HMW, van der Zee L, Wijffels MC, van Leuven C, Dorland R, Vos MA, Jongsma HJ, Allessie MA. Atrial fibrillation in the goat induces changes in monophasic action potential and mRNA expression of ion channels involved in repolarization. J Cardiovasc Electrophysiol. 2000;11:1262-1269.
6. Van Wagoner DR, Pond AL, Lamorgese M, Rossie SS, McCarthy PM, Nerbonne JM. Atrial L-type Ca2+ currents and human atrial fibrillation. Circ Res. 1999;85:428-436.
7. Casaclang-Verzosa G, Gersh BJ, Tsang TS. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol. 2008;51:1-11.
8. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation. 1996;94: 2968-2974.
9. Ausma J, Dispersyn GD, Duimel H, Thone F, Ver Donck L, Allessie MA, Borgers M. Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. J Mol Cell Cardiol. 2000;32:355-364.
10. Yue L, Melnyk P, Gaspo R, Wang Z, Nattel S. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. Circ Res. 1999;84:776-784.
11. Yue L, Feng J, Li GR, Nattel S. Transient outward and delayed rectifier currents in canine atrium: properties and role of isolation methods. Am J Physiol. 1996;270:H2157-H2168.
12. Zhang LM, Wang Z, Nattel S. Effects of sustained beta-adrenergic stimulation on ionic currents of cultured adult guinea pig cardiomyocytes. Am J Physiol. 2002;282:H880-H889.
13. Coutu P, Chartier D, Nattel S. Comparison of Ca2+-handling properties of canine pulmonary vein and left atrial cardiomyocytes. Am J Physiol. 2006;291:H2290-H2300.
14. Burstein B, Qi XY, Yeh YH, Calderone A, Nattel S. Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling. Cardiovasc Res. 2007;76:442-452.
15. Brundel BJ, van Gelder IC, Henning RH, Tuinenburg AE, Deelman LE, Tieleman RG, Grandjean JG, van Gilst WH, Crijns HJ. Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. Cardiovasc Res. 1999;42:443-454.
16. Walsh MP, Le Peuch CJ, Vallet B, Cavadore JC, Demaille JG. Cardiac calmodulin and its role in the regulation of metabolism and contraction. J Mol Cell Cardiol. 1980;12:1091-1101.
17. Molkentin JD. Calcineurin and beyond: cardiac hypertrophic signaling. Circ Res. 2000;87:731-738.
18. Rossow CF, Minami E, Chase EG, Murry CE, Santana LF. NFATc3-induced reductions in voltage-gated K+ currents after myocardial infarction. Circ Res. 2004;94:1340-1350.
19. Tavi P, Pikkarainen S, Ronkainen J, Niemela P, Ilves M, Weckstrom M, Vuolteenaho O, Bruton J, Westerblad H, Ruskoaho H. Pacing-induced calcineurin activation controls cardiac Ca2+ signalling and gene expression. J Physiol. 2004;554:309-320.
20. Bosch RF, Zeng X, Grammer JB, Popovic K, Mewis C, Kuhlkamp V. Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res. 1999;44:121-131.
21. Brundel BJ, Van Gelder IC, Henning RH, Tieleman RG, Tuinenburg AE, Wietses M, Grandjean JG, Van Gilst WH, Crijns HJ. Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation. 2001;103:684-690.
22. Klein G, Schroder F, Vogler D, Schaefer A, Haverich A, Schieffer B, Korte T, Drexler H. Increased open probability of single cardiac L-type calcium channels in patients with chronic atrial fibrillation. Role of phosphatase 2A. Cardiovasc Res. 2003;59:37-45.
23. Leistad E, Aksnes G, Verburg E, Christensen G. Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644. Circulation. 1996;93:1747-1754.
24. Sun H, Chartier D, Leblanc N, Nattel S. Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes. Cardiovasc Res. 2001;49:751-761.
25. Bukowska A, Lendeckel U, Hirte D, Wolke C, Striggow F, Rohnert P, Huth C, Klein HU, Goette A. Activation of the calcineurin signaling pathway induces atrial hypertrophy during atrial fibrillation. CellMol Life Sci. 2006;63:333-342.
26. Lin CC, Lin JL, Lin CS, Tsai MC, Su MJ, Lai LP, Huang SK. Activation of the calcineurin-nuclear factor of activated T-cell signal transduction pathway in atrial fibrillation. Chest. 2004;126:1926-1932.
27. Maier LS, Ziolo MT, Bossuyt J, Persechini A, Mestril R, Bers DM. Dynamic changes in free Ca-calmodulin levels in adult cardiac myocytes. J Mol Cell Cardiol. 2006;41:451-458.
28. Xia Y, McMillin JB, Lewis A, Moore M, Zhu WG, Williams RS, Kellems RE. Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and up-regulates the adenylosuccinate synthetase 1 gene. J Biol Chem. 2000;275:1855-1863.
29. Crabtree GR. Pi-by-no signals and specific outcomes: signaling through Ca2 +, calcineurin, and NF-AT. Cell. 1999;96:611-614.
30. Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003;17:2205-2232.
31. Dolmetsch RE, Lewis RS, Goodnow CC, Healy JI. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature. 1997;386:855-858.
32. Dong D, Duan Y, Guo J, Roach DE, Swirp SL, Wang L, Lees-Miller JP, Sheldon RS, Molkentin JD, Duff HJ. Overexpression of calcineurin in mouse causes sudden cardiac death associated with decreased density of K+ channels. Cardiovasc Res. 2003;57:320-332.
33. Perrier E, Perrier R, Richard S, Benitah JP. Ca2+ controls functional expression of the cardiac K+ transient outward current via the calcineurin pathway. J Biol Chem. 2004;279:40634-40639.
34. Rossow CF, Dilly KW, Santana LF. Differential calcineurin/NFATc3 activity contributes to the Ito transmural gradient in the mouse heart. Circ Res. 2006;98:1306-1313.
35. Gong N, Bodi I, Zobel C, Schwartz A, Molkentin JD, Backx PH. Calcineurin increases cardiac transient outward K+ currents via transcriptional up-regulation of Kv4.2 channel subunits. J Biol Chem. 2006;281: 38498-38506.
36. Yatani A, Honda R, Tymitz KM, Lalli MJ, Molkentin JD. Enhanced Ca2+ channel currents in cardiac hypertrophy induced by activation of calcineurin-dependent pathway. J Mol Cell Cardiol. 2001;33:249-259.
37. Nattel S, Maguy A, Le Bouter S, Yeh Y-H. Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev. 2007;87:425-456. (Pubitemid 47084677)
38. Yang Z, Shen W, Rottman JN, Wikswo JP, Murray KT. Rapid stimulation causes electrical remodeling in cultured atrial myocytes. J Mol Cell Cardiol. 2005;38:299-308.
39. Burashnikov A, Mannava S, Antzelevitch C. Transmembrane action potential heterogeneity in the canine isolated arterially perfused right atrium: effect of IKr and IKu/Ito block. Am J Physiol Heart Circ Physiol. 2004;286:H2393-H2400.
40. Voigt N, Friedrich A, Bock M, Wettwer E, Christ T, Knaut M, Strasser RH, Ravens U, Dobrev D. Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation. Cardiovasc Res. 2007;74:426-437.
41. Murray KT, Mace LC, Yang Z. Nonantiarrhythmic drug therapy for atrial fibrillation. Heart Rhythm. 2007;4(suppl 3):S88-S90